奥福环保(688021) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥96,050,965.58, representing a year-on-year increase of 34.04% compared to ¥71,659,976.07 in the same period last year[4] - The net profit attributable to shareholders of the listed company was -¥3,269,811.01, an improvement from -¥8,777,723.29 in the previous year, indicating a 62.75% reduction in losses[8] - The net profit for Q1 2025 was a loss of ¥3,621,275.51, an improvement from a loss of ¥9,527,161.04 in Q1 2024[16] - The total comprehensive income for the period was CNY -2,865,163.63, compared to CNY -6,372,200.89 in the previous year[26] Cash Flow - The net cash flow from operating activities was ¥4,703,106.89, a significant increase of 366.21% compared to -¥1,766,664.26 in the same period last year[8] - The total cash inflow from operating activities was ¥69,913,096.80, while cash outflow was ¥65,209,989.91, resulting in a net cash inflow[17] - The net cash flow from operating activities was CNY 26,764,531.05, a significant improvement from a net outflow of CNY -13,395,193.78 in the same period last year[27] - The cash inflow from financing activities in Q1 2025 was ¥48,400,000.00, while cash outflow was ¥56,685,616.56, resulting in a net cash flow of -¥8,285,616.56[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,188,117,456.57, a slight decrease of 0.17% from ¥1,190,194,186.69 at the end of the previous year[5] - The company's total liabilities as of the end of the reporting period were ¥328,372,484.68, slightly up from ¥326,835,799.83[14] - The total liabilities as of March 31, 2025, were ¥207,496,296.46, compared to ¥212,084,454.43 at the end of 2024[24] Earnings Per Share - The basic earnings per share were -¥0.04, an improvement from -¥0.11 in the same period last year, reflecting a 63.64% reduction in losses per share[8] - Basic and diluted earnings per share for Q1 2025 were both -¥0.04, an improvement from -¥0.11 in Q1 2024[17] Research and Development - Research and development expenses totaled ¥5,034,489.29, accounting for 5.24% of operating revenue, down from 7.87% in the previous year, a decrease of 2.63 percentage points[5] - Research and development expenses for Q1 2025 were ¥5,034,489.29, compared to ¥5,641,857.43 in Q1 2024, indicating a decrease of 10.7%[15] - The company incurred research and development expenses of ¥803,713.25 in Q1 2025, significantly lower than ¥2,899,070.90 in Q1 2024[24] Inventory and Receivables - Accounts receivable rose to CNY 145,806,084.10 from CNY 118,921,732.17, indicating an increase of approximately 22.63%[12] - The company reported a decrease in accounts receivable from ¥154,659,208.22 in Q1 2024 to ¥123,567,656.38 in Q1 2025, indicating improved collection efficiency[22] - The company's inventory decreased from ¥138,828,144.25 in Q1 2024 to ¥132,940,051.00 in Q1 2025, suggesting better inventory management[22] Shareholding Structure - The company reported a total of 10,743,827 shares held by the largest shareholder, accounting for 14.06% of total shares[11] - The company has no significant changes in the shareholding structure or any related party transactions reported during the period[12]